private:koelis-2
|
1301492
|
Dec 3rd, 2020 12:00AM
|
KOELIS
|
1.7K
|
64.00
|
Open
|
Medical Device
|
Dec 3rd, 2020 11:15AM
|
Dec 3rd, 2020 11:15AM
|
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment.
Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence.
The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Boston, KOELIS technology has been featured in more than 50 clinical publications and treats more than 150,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.
|
Open
|
Medical Device, Medical Imaging, Image Guided Surgery, Urology, Image Fusion, Focal Therapy, prostate biopsy fusion, prostate cancer, prostate treatment, prostate therapy, radiology, pro
|
Open
|
16 Chemin du vieux chêne
|
Meylan
|
|
FR
|
38240
|
|
KOELIS
|
|
Pharmaceuticals & Biotechnology
|
private:koelis-2
|
1301492
|
Dec 2nd, 2020 12:00AM
|
KOELIS
|
1.7K
|
65.00
|
Open
|
Medical Device
|
Dec 2nd, 2020 01:36PM
|
Dec 2nd, 2020 01:36PM
|
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment.
Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence.
The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Boston, KOELIS technology has been featured in more than 50 clinical publications and treats more than 150,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.
|
Open
|
Medical Device, Medical Imaging, Image Guided Surgery, Urology, Image Fusion, Focal Therapy, prostate biopsy fusion, prostate cancer, prostate treatment, prostate therapy, radiology, pro
|
Open
|
16 Chemin du vieux chêne
|
Meylan
|
|
FR
|
38240
|
|
KOELIS
|
|
Pharmaceuticals & Biotechnology
|
private:koelis-2
|
1301492
|
Dec 1st, 2020 12:00AM
|
KOELIS
|
1.7K
|
65.00
|
Open
|
Medical Device
|
Dec 1st, 2020 01:11PM
|
Dec 1st, 2020 01:11PM
|
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment.
Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence.
The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Boston, KOELIS technology has been featured in more than 50 clinical publications and treats more than 150,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.
|
Open
|
Medical Device, Medical Imaging, Image Guided Surgery, Urology, Image Fusion, Focal Therapy, prostate biopsy fusion, prostate cancer, prostate treatment, prostate therapy, radiology, pro
|
Open
|
16 Chemin du vieux chêne
|
Meylan
|
|
FR
|
38240
|
|
KOELIS
|
|
Pharmaceuticals & Biotechnology
|
private:koelis-2
|
1301492
|
Nov 30th, 2020 12:00AM
|
KOELIS
|
1.7K
|
65.00
|
Open
|
Medical Device
|
Nov 29th, 2020 07:16PM
|
Nov 30th, 2020 02:02PM
|
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment.
Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence.
The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Boston, KOELIS technology has been featured in more than 50 clinical publications and treats more than 150,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.
|
Open
|
Medical Device, Medical Imaging, Image Guided Surgery, Urology, Image Fusion, Focal Therapy, prostate biopsy fusion, prostate cancer, prostate treatment, prostate therapy, radiology, pro
|
Open
|
16 Chemin du vieux chêne
|
Meylan
|
|
FR
|
38240
|
|
KOELIS
|
|
Pharmaceuticals & Biotechnology
|
private:koelis-2
|
1301492
|
Nov 28th, 2020 12:00AM
|
KOELIS
|
1.7K
|
65.00
|
Open
|
Medical Device
|
Nov 28th, 2020 02:51PM
|
Nov 28th, 2020 02:51PM
|
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment.
Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence.
The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Boston, KOELIS technology has been featured in more than 50 clinical publications and treats more than 150,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.
|
Open
|
Medical Device, Medical Imaging, Image Guided Surgery, Urology, Image Fusion, Focal Therapy, prostate biopsy fusion, prostate cancer, prostate treatment, prostate therapy, radiology, pro
|
Open
|
16 Chemin du vieux chêne
|
Meylan
|
|
FR
|
38240
|
|
KOELIS
|
|
Pharmaceuticals & Biotechnology
|
private:koelis-2
|
1301492
|
Nov 27th, 2020 12:00AM
|
KOELIS
|
1.7K
|
65.00
|
Open
|
Medical Device
|
Nov 27th, 2020 11:16AM
|
Nov 27th, 2020 11:16AM
|
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment.
Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence.
The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Boston, KOELIS technology has been featured in more than 50 clinical publications and treats more than 150,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.
|
Open
|
Medical Device, Medical Imaging, Image Guided Surgery, Urology, Image Fusion, Focal Therapy, prostate biopsy fusion, prostate cancer, prostate treatment, prostate therapy, radiology, pro
|
Open
|
16 Chemin du vieux chêne
|
Meylan
|
|
FR
|
38240
|
|
KOELIS
|
|
Pharmaceuticals & Biotechnology
|
private:koelis-2
|
1301492
|
Nov 26th, 2020 12:00AM
|
KOELIS
|
1.7K
|
65.00
|
Open
|
Medical Device
|
Nov 26th, 2020 12:15PM
|
Nov 26th, 2020 12:15PM
|
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment.
Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence.
The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Boston, KOELIS technology has been featured in more than 50 clinical publications and treats more than 150,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.
|
Open
|
Medical Device, Medical Imaging, Image Guided Surgery, Urology, Image Fusion, Focal Therapy, prostate biopsy fusion, prostate cancer, prostate treatment, prostate therapy, radiology, pro
|
Open
|
16 Chemin du vieux chêne
|
Meylan
|
|
FR
|
38240
|
|
KOELIS
|
|
Pharmaceuticals & Biotechnology
|
private:koelis-2
|
1301492
|
Nov 25th, 2020 12:00AM
|
KOELIS
|
1.7K
|
65.00
|
Open
|
Medical Device
|
Nov 25th, 2020 05:35PM
|
Nov 25th, 2020 05:35PM
|
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment.
Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence.
The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Boston, KOELIS technology has been featured in more than 50 clinical publications and treats more than 150,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.
|
Open
|
Medical Device, Medical Imaging, Image Guided Surgery, Urology, Image Fusion, Focal Therapy, prostate biopsy fusion, prostate cancer, prostate treatment, prostate therapy, radiology, pro
|
Open
|
16 Chemin du vieux chêne
|
Meylan
|
|
FR
|
38240
|
|
KOELIS
|
|
Pharmaceuticals & Biotechnology
|
private:koelis-2
|
1301492
|
Nov 24th, 2020 12:00AM
|
KOELIS
|
1.7K
|
65.00
|
Open
|
Medical Device
|
Nov 24th, 2020 12:48PM
|
Nov 24th, 2020 12:48PM
|
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment.
Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence.
The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Boston, KOELIS technology has been featured in more than 50 clinical publications and treats more than 150,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.
|
Open
|
Medical Device, Medical Imaging, Image Guided Surgery, Urology, Image Fusion, Focal Therapy, prostate biopsy fusion, prostate cancer, prostate treatment, prostate therapy, radiology, pro
|
Open
|
16 Chemin du vieux chêne
|
Meylan
|
|
FR
|
38240
|
|
KOELIS
|
|
Pharmaceuticals & Biotechnology
|
private:koelis-2
|
1301492
|
Nov 23rd, 2020 12:00AM
|
KOELIS
|
1.7K
|
65.00
|
Open
|
Medical Device
|
Nov 23rd, 2020 02:53PM
|
Nov 23rd, 2020 02:53PM
|
KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment.
Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full 3D ultrasound, any suspicious lesion is characterized in a detailed 3D prostate map, offering a comprehensive and multiparametric approach and enhancing diagnostic confidence.
The team at KOELIS innovates every day in collaboration with world-renowned universities and hospitals to offer physicians new advancements in imaging and a greater field of view, a must-have in active surveillance and targeted treatment. Based in Grenoble and Boston, KOELIS technology has been featured in more than 50 clinical publications and treats more than 150,000 patients worldwide, including patients in Europe, United States, Canada, Japan, Australia, South America and the Middle East.
|
Open
|
Medical Device, Medical Imaging, Image Guided Surgery, Urology, Image Fusion, Focal Therapy, prostate biopsy fusion, prostate cancer, prostate treatment, prostate therapy, radiology, pro
|
Open
|
16 Chemin du vieux chêne
|
Meylan
|
|
FR
|
38240
|
|
KOELIS
|
|
Pharmaceuticals & Biotechnology
|